Advancing Neural Disease Modeling with Human iPSC-Derived Cell Systems

Human induced pluripotent stem cell (iPSC) technology has enabled the generation of virtually any human cell type from somatic cells obtained from healthy or disease donors. This powerful platform has significantly enhanced the physiological relevance of in vitro models by bridging the gap between traditional animal studies and human diseases, particularly in the field of neuroscience. 

Today, a wide range of neural cell types can be robustly derived from both healthy and disease-specific iPSCs. When integrated into modular two-dimensional (2D) and three-dimensional (3D) assay workflows, these human iPSC-derived neural cells provide a novel and highly relevant approach to complement existing research tools. Such systems enable increased biological complexity and improved translational value for neural disease modeling and drug testing. 

In this webinar, we will highlight a holistic solution for neural disease modeling, featuring iCell® iPSC-derived neural disease models from Fujifilm Cellular Dynamics, alongside complementary Fujifilm Biosciences reagents designed to support robust, reproducible, and scalable neural assays. 

Learning Objectives:

1. Describe how human iPSC-derived neural cells improve the physiological relevance of in vitro models compared to traditional animal and cell lines.

2. Evaluate the advantages of integrating human iPSC-derived cells into 2D and 3D assay workflows for neural disease modeling and drug testing.

3. Gain insights into how iPSC-derived systems recapitulate key human neurological characteristics to provide a reliable platform for disease modeling.